Ripple will drop cross-appeal in SEC case, get refund from lower court ruling

OptiScan Biomedical

company

About

OptiScan Biomedical develops glucose monitoring systems to assist healthcare providers to manage the glucose level of the patients.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$36M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 1994
Number Of Employee
51 - 100
Operating Status
Active

OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$36M
OptiScan Biomedical has raised a total of $36M in funding over 2 rounds. Their latest funding was raised on Oct 10, 2005 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 10, 2005 Series Unknown $36M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
OptiScan Biomedical is funded by 1 investors. EGS Healthcare Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
EGS Healthcare Capital Partners Series Unknown